Covestor
ARQT icon

Covestor’s Arcutis Biotherapeutics ARQT Stock Holding History

Covestor’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$56K Sell
2,130
-6
-0.3% -$157 0.04% 678
2026
Q2 		$56K Buy
2,136
+2,128
+26,600% +$49.6K 0.03% 728
2026
Q1 		$0 Sell
8
-1
-11% -$26 ﹤0.01% 2239
2025
Q4 		$0 Hold
9
– – ﹤0.01% 2245
2025
Q3 		$0 Hold
9
– – ﹤0.01% 2264
2025
Q2 		$0 Sell
9
-1
-10% -$14 ﹤0.01% 2187
2025
Q1 		$0 Hold
10
– – ﹤0.01% 2190
2024
Q4 		$0 Buy
10
+1
+11% +$11 ﹤0.01% 2207
2024
Q3 		$0 Sell
9
-1
-10% -$10 ﹤0.01% 2187
2024
Q2 		$0 Hold
10
– – ﹤0.01% 2219
2024
Q1 		$0 Sell
10
-8
-44% -$60 ﹤0.01% 2213
2023
Q4 		$0 Buy
18
+11
+157% +$30 ﹤0.01% 2119
2023
Q3 		$0 Sell
7
-1
-13% -$9 ﹤0.01% 2088
2023
Q2 		$0 Hold
8
– – ﹤0.01% 2105
2023
Q1 		$0 Hold
8
– – ﹤0.01% 1990
2022
Q4 		$0 Sell
8
-1
-11% -$17 ﹤0.01% 2035
2022
Q3 		$0 Sell
9
-1
-10% -$23 ﹤0.01% 1954
2022
Q2 		$0 Buy
+10
New +$205 ﹤0.01% 1879
2022
Q1 		– Sell
-16
Closed – – 2080
2021
Q4 		$0 Buy
+16
New +$318 ﹤0.01% 2096

Other funds holding ARQT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return

Covestor's ARQT Position: Q3 2026 in Review

Covestor reduced its Arcutis Biotherapeutics (ARQT) stake by 0.28% in Q3 2026, selling an estimated $157 and leaving 2,130 shares worth $56K. The position accounts for 0.04% of the portfolio, ranked #678.

Covestor first reported a position in ARQT in Q4 2021 and has held it in 19 quarters since. 212 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.

  • Covestor held 2,130 shares of Arcutis Biotherapeutics worth $56K as of Q3 2026.
  • Covestor sold 6 Arcutis Biotherapeutics shares in Q3 2026, an estimated $157.
  • Arcutis Biotherapeutics made up 0.04% of Covestor's portfolio in Q3 2026, its #678 holding.
  • Covestor first reported a position in Arcutis Biotherapeutics in Q4 2021 and has held it in 19 quarters since.
  • 212 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.